Search research articles
Contact Us
Filters
Showing results (51-60 of 71) with videos related to
Page
of 8
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
May 19, 2018
Cefepime vs. cefoperazone/sulbactam in combination with amikacin as empirical antibiotic therapy in febrile neutropenia
M Ponraj, Biswajit Dubashi, B H Harish, et al.
Journal of Pharmacological and Toxicological Methods
|
November 5, 2022
Determination of five positive control drugs in hERG external solution (buffer) by LC-MS/MS to support in vitro hERG assay as recommended by ICH S7B
Tamara I King, Amruta Indapurkar, Isra Tariq, et al.
Journal of Pharmaceutical Sciences
|
October 16, 2024
Changes in drug crystallinity in a commercial tacrolimus amorphous formulation result in variable pharmacokinetics
Lynne S Taylor, Niraj S Trasi, Hitesh S Purohit, et al.
AAPS Pharmscitech
|
April 23, 2022
In Vitro Testing of Sunscreens for Dermal Absorption: Method Comparison and Rank Order Correlation with In Vivo Absorption
Yang Yang, Ann-Marie Ako-Adounvo, Jiang Wang, et al.
Clinical Pharmacology and Therapeutics
|
November 18, 2018
Assessment of Multi-Ion Channel Block in a Phase I Randomized Study Design: Results of the CiPA Phase I ECG Biomarker Validation Study
Jose Vicente, Robbert Zusterzeel, Lars Johannesen, et al.
Clinical Pharmacology and Therapeutics
|
October 2, 2022
Considerations for Use of Pharmacodynamic Biomarkers to Support Biosimilar Development - (II) A Randomized Trial with IL-5 Antagonists
Victoria Gershuny, Qin Sun, Sarah J Schrieber, et al.
Clinical Pharmacology and Therapeutics
|
October 25, 2022
Considerations for Use of Pharmacodynamic Biomarkers to Support Biosimilar Development - (I) A Randomized Trial with PCSK9 Inhibitors
Morasa Sheikhy, Sarah J Schrieber, Qin Sun, et al.
Clinical and Translational Science
|
December 31, 2020
Characterizing the reproducibility in using a liver microphysiological system for assaying drug toxicity, metabolism, and accumulation
Andrés Rubiano, Amruta Indapurkar, Ryosuke Yokosawa, et al.
Clinical Pharmacology and Therapeutics
|
November 3, 2022
Considerations for Use of Pharmacodynamic Biomarkers to Support Biosimilar Development - (III) A Randomized Trial with Interferon Beta-1a Products
Jeffry Florian, Victoria Gershuny, Qin Sun, et al.
Clinical Pharmacology and Therapeutics
|
July 4, 2025
Characterization of Proteomic Pharmacodynamic Biomarkers of IFNβ-1a Biologics to Inform Potential Utility in Biosimilar Development
Lakshmi Manasa S Chekka, Deepti P Samarth, Yan Guo, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 71) with videos related to
Sort By:
Page
of 8
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
May 19, 2018
Cefepime vs. cefoperazone/sulbactam in combination with amikacin as empirical antibiotic therapy in febrile neutropenia
M Ponraj, Biswajit Dubashi, B H Harish, et al.
Journal of Pharmacological and Toxicological Methods
|
November 5, 2022
Determination of five positive control drugs in hERG external solution (buffer) by LC-MS/MS to support in vitro hERG assay as recommended by ICH S7B
Tamara I King, Amruta Indapurkar, Isra Tariq, et al.
Journal of Pharmaceutical Sciences
|
October 16, 2024
Changes in drug crystallinity in a commercial tacrolimus amorphous formulation result in variable pharmacokinetics
Lynne S Taylor, Niraj S Trasi, Hitesh S Purohit, et al.
AAPS Pharmscitech
|
April 23, 2022
In Vitro Testing of Sunscreens for Dermal Absorption: Method Comparison and Rank Order Correlation with In Vivo Absorption
Yang Yang, Ann-Marie Ako-Adounvo, Jiang Wang, et al.
Clinical Pharmacology and Therapeutics
|
November 18, 2018
Assessment of Multi-Ion Channel Block in a Phase I Randomized Study Design: Results of the CiPA Phase I ECG Biomarker Validation Study
Jose Vicente, Robbert Zusterzeel, Lars Johannesen, et al.
Clinical Pharmacology and Therapeutics
|
October 2, 2022
Considerations for Use of Pharmacodynamic Biomarkers to Support Biosimilar Development - (II) A Randomized Trial with IL-5 Antagonists
Victoria Gershuny, Qin Sun, Sarah J Schrieber, et al.
Clinical Pharmacology and Therapeutics
|
October 25, 2022
Considerations for Use of Pharmacodynamic Biomarkers to Support Biosimilar Development - (I) A Randomized Trial with PCSK9 Inhibitors
Morasa Sheikhy, Sarah J Schrieber, Qin Sun, et al.
Clinical and Translational Science
|
December 31, 2020
Characterizing the reproducibility in using a liver microphysiological system for assaying drug toxicity, metabolism, and accumulation
Andrés Rubiano, Amruta Indapurkar, Ryosuke Yokosawa, et al.
Clinical Pharmacology and Therapeutics
|
November 3, 2022
Considerations for Use of Pharmacodynamic Biomarkers to Support Biosimilar Development - (III) A Randomized Trial with Interferon Beta-1a Products
Jeffry Florian, Victoria Gershuny, Qin Sun, et al.
Clinical Pharmacology and Therapeutics
|
July 4, 2025
Characterization of Proteomic Pharmacodynamic Biomarkers of IFNβ-1a Biologics to Inform Potential Utility in Biosimilar Development
Lakshmi Manasa S Chekka, Deepti P Samarth, Yan Guo, et al.
Page
of 8